���Ĺ���ý

The Embark Deep Tech Startup Creator at Venture Partners at CU Boulder has officially launched its first Embark Entrepreneurs in Residence cohort. Embark aims to connect business minds outside the university with breakthrough inventions emerging from CU Boulder's research labs to bring them to market and unleash the full impact of CU Boulder's research into the world.

College of Engineering and Applied Science—Srubar's lab conducts major research into biomimetic and living materials that have the potential to drastically reduce environmental pollution caused by construction activities around the globe.

College of Engineering and Applied Science—Svenja Knappe and her colleagues have developed a helmet that contains 128 sensors and is customizable for different sizes of the human head. Knappe founded the Boulder-based company FieldLine and has begun to bring these sensors to market. In the not-so-distant future, they could aid in the diagnosis and treatment of a wide range of neurological conditions like epilepsy, autism and traumatic brain injuries.

CU Boulder Today—Chemists at CU Boulder have developed a new way to recycle a common type of plastic found in soda bottles and other packaging and are working with Venture Partners at CU Boulder to bring it to real-world applications. The team’s method relies on electricity and some nifty chemical reactions, and it’s simple enough that you can watch the plastic break apart in front of your eyes.

CU Boulder Today—In 2016, Pfizer began collaborating with Sabrina Spencer, a global leader in time-lapse cell imaging and member of the CU Cancer Center, to study how cancer cells respond to their potent new drugs called CDK2 inhibitors.

CU Boulder researcher Linda Watkins and CU startups Beryl Therapeutics Inc., Modendo Inc. and TissueForm Inc. are among 37 companies and researchers awarded Proof of Concept and Early-Stage Capital Retention grants through the Colorado Office of Economic Development and International Trade (OEDIT).

CU Boulder researchers have identified a surprising new player in ALS (amyotrophic lateral sclerosis)—an ancient, virus-like protein. With funding from the ALS Association, the National Institutes of Health, and Venture Partners at CU Boulder, Alexandra Whiteley's lab is now working to understand the molecular pathways involved and to find a way of inhibiting the rogue protein.

NIST—Researchers at the National Institute of Standards and Technology (NIST) and CU Boulder have fabricated a novel device that could dramatically boost the conversion of heat into electricity. If perfected, the technology could help recoup some of

Say “hello” to the robots of the future: They’re soft and flexible enough to bounce off walls or squeeze into tight spaces. And when you’re done with them, you can toss these machines into a compost bin to decompose.

Vitro3D, a CU Boulder startup pioneering volumetric 3D printing for life sciences, just closed its first investment round of $1.3 million. The hard-won vote of confidence from the investment community will allow the promising new venture to pursue ambitious technical advances while continuing to build critical business capacity.